338 filings
Page 8 of 17
8-K
5hixkb
4 Jun 19
Sorrento announces Cannabidiol (CBD) global joint ventures and commercial strategic partnerships
7:00am
8-K
pmiz9zw
21 May 19
Getting Back to Normal Scilex Corporate Presentation May 2019 Non - Confidential 1
5:07pm
8-K
oaphd grv
13 May 19
Results of Operations and Financial Condition
4:02pm
8-K
lbpd3
3 May 19
Entry into a Material Definitive Agreement
4:01pm
8-K
il4ykskhicer2a6to
16 Apr 19
Regulation FD Disclosure
9:00am
8-K
xbo38rb2dsw9l8y2
15 Apr 19
Getting Back to Normal Scilex Corporate Presentation April 2019 Non - Confidential 1
6:08am
8-K/A
474v7 xis
3 Apr 19
Other Events
1:14pm
8-K
izjday716eh0aezvm8g
3 Apr 19
Regulation FD Disclosure
9:01am
8-K
wendfe5c1ot18yt
22 Mar 19
Entry into a Material Definitive Agreement
7:00am
8-K
rfa7tgohyg6
15 Feb 19
Results of Operations and Financial Condition
12:00am
8-K
tr26k0 u7oay
23 Jan 19
Other Events
9:35pm
8-K
vshfhwc1i ut
22 Jan 19
Regulation FD Disclosure
7:00am
8-K
1lks8xz
16 Nov 18
Entry into a Material Definitive Agreement
4:04pm
8-K
kylkpzbotpy gkm0as
8 Nov 18
Sorrento Therapeutics Closes FIVE-YEAR TERM LOAN Financing For up to $150 Million
7:00am
8-K
r86w8ckwp89ydqvn6
10 Sep 18
Scilex plans to launch ZTlido™ (lidocaine topical system) 1.8% in October 2018
12:00am
8-K
wuhx5ys2 9x
28 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
92znsb42y es60yukk
14 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
oi2wa7lgba
27 Apr 18
Entry into a Material Definitive Agreement
9:00am
8-K
f17li
18 Apr 18
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
25zy11r4 es
5 Apr 18
Regulation FD Disclosure
12:00am